Analyze Diet
New Zealand veterinary journal2006; 54(4); 178-184; doi: 10.1080/00480169.2006.36692

Effects of initial and extended exposure to an endophyte-infected tall fescue seed diet on faecal and urinary excretion of ergovaline and lysergic acid in mature geldings.

Abstract: To determine the amount of ergovaline and lysergic acid retained or excreted by geldings fed endophyte-infected seed containing known concentrations of these alkaloids, and the effects of exposure time on clinical expression of toxicosis. Methods: Mature geldings (n=10) received diets containing either endophyte-free (E-) or endophyte-infected (E+) tall fescue seed during three experimental phases. The first phase (Days -14 to -1) was an adaptation phase, to allow all horses to adapt to a diet containing E- tall fescue seed. The second (Days 0 to 3) was the initial exposure phase to E+ tall fescue seed, used for the delivery of ergovaline and lysergic acid at 0.5 and 0.3 mg/kg of diet, respectively, to test the initial effects of exposure on routes and amounts of elimination of alkaloid. During this phase, half the geldings were exposed to an E+ diet while the rest served as controls by remaining on the E- diet. Once assigned to treatments, geldings remained on the same diet through the third phase (Days 4 to 21), which served as the extended exposure phase. Total outputs of faeces and urine were collected within each phase, to determine retention of ergovaline and lysergic acid and nutrient digestibility. Serum was collected weekly and analysed for activities of enzymes and concentrations of prolactin. Bodyweights (BW) and rectal temperatures were recorded weekly. Results: BW, rectal temperature, enzyme activities and concentrations of prolactin in serum, and nutrient digestibility were not affected by treatment. Total intake of ergovaline by geldings on the E+ diet was 3.5 and 3.6 (SE 0.20) mg/day, and 2.1 and 2.3 (SE 0.11) mg/day were not accounted for in initial and extended phases, respectively. Lysergic acid was excreted in the urine (4.0 and 4.9 (SE 0.97) mg/day) and faeces (2.5 and 2.7 (SE 0.35) mg/day) at greater amounts than that consumed (2.0 and 1.9 (SE 0.09) mg/day) during the initial and extended exposure phases, respectively. Animals exposed to E+ seed for a period of 20 days appeared to excrete more (1.5 vs 1.2 mg/day; SE 0.08; p=0.03) ergovaline in the faeces than those exposed for only 4 days. Conclusions: Exposure time to the ergot alkaloids had a limited effect on the route of elimination or the amounts of ergovaline or lysergic acid excreted by horses. The primary alkaloid excreted was lysergic acid, and urine was the major route of elimination. These data will aid future research to improve animals' tolerance to toxic endophyte-infected tall fescue.
Publication Date: 2006-08-18 PubMed ID: 16915339DOI: 10.1080/00480169.2006.36692Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article investigates how geldings (castrated horses) retain or excrete ergovaline and lysergic acid when fed a diet containing endophyte-infected tall fescue seeds, and how exposure time affects toxicosis symptoms.

Research Methodology

  • The study was conducted on 10 mature geldings throughout three distinct experimental phases: adaptation, initial exposure, and extended exposure.
  • The adaptation phase was to get all the horses accustomed to a diet with endophyte-free (E-) tall fescue seed.
  • In the initial exposure phase, some horses were fed endophyte-infected (E+) seeds at specific ergovaline and lysergic acid concentrations, while others continued with the E- diet as a control group.
  • The extended exposure phase saw the horses maintain their previous diets.
  • The researchers collected total faecal and urine outputs within each phase to determine the retention of ergovaline and lysergic acid and nutrient digestibility.
  • Serum was collected weekly for enzyme activities and prolactin concentration analysis.
  • Body weight and rectal temperatures of the horses were also recorded weekly to monitor their health status.

Research Findings

  • No significant changes were observed regarding body weight, rectal temperature, enzyme activities, prolactin concentrations in serum, and nutrient digestibility.
  • Ergovaline intake was found to be higher in geldings on the E+ diet, but some of it was not accounted for in both initial and extended exposure phases.
  • Interestingly, lysergic acid excreted in urine and faeces was greater than what was consumed during both exposure phases.
  • Additionally, horses exposed to the E+ diet for 20 days were observed to excrete more ergovaline in their faeces compared to those exposed for only 4 days.

Research Conclusions

  • The length of exposure to ergot alkaloids did not significantly affect the elimination route or the amounts of ergovaline or lysergic acid excreted by the horses.
  • Lysergic acid was identified as the primary alkaloid excreted, and urine was recognized as the major elimination route.
  • These findings will aid in future research aimed at improving animals’ tolerance to toxic endophyte-infected tall fescue.

Cite This Article

APA
Schultz CL, Lodge-Ivey SL, Bush LP, Craig AM, Strickland JR. (2006). Effects of initial and extended exposure to an endophyte-infected tall fescue seed diet on faecal and urinary excretion of ergovaline and lysergic acid in mature geldings. N Z Vet J, 54(4), 178-184. https://doi.org/10.1080/00480169.2006.36692

Publication

ISSN: 0048-0169
NlmUniqueID: 0021406
Country: England
Language: English
Volume: 54
Issue: 4
Pages: 178-184

Researcher Affiliations

Schultz, C L
  • USDA, ARS Southern Plains Agricultural Center, 2881 F&B Road, College Station, TX 77845, USA.
Lodge-Ivey, S L
    Bush, L P
      Craig, A M
        Strickland, J R

          MeSH Terms

          • Animal Feed / microbiology
          • Animals
          • Biological Availability
          • Body Weight / drug effects
          • Digestion
          • Dose-Response Relationship, Drug
          • Ergotamines / blood
          • Ergotamines / metabolism
          • Ergotamines / urine
          • Feces / chemistry
          • Food Contamination
          • Horses / blood
          • Horses / metabolism
          • Horses / urine
          • Hypocreales / growth & development
          • Lysergic Acid / blood
          • Lysergic Acid / metabolism
          • Lysergic Acid / urine
          • Male
          • Poaceae / microbiology
          • Prolactin / blood
          • Random Allocation
          • Time Factors
          • Urinalysis / veterinary

          Citations

          This article has been cited 4 times.
          1. Britt JL, Greene MA, Bridges WC, Klotz JL, Aiken GE, Andrae JG, Pratt SL, Long NM, Schrick FN, Strickland JR, Wilbanks SA, Miller MF, Koch BM, Duckett SK. Ergot alkaloid exposure during gestation alters. I. Maternal characteristics and placental development of pregnant ewes1.. J Anim Sci 2019 Apr 3;97(4):1874-1890.
            doi: 10.1093/jas/skz068pubmed: 30895321google scholar: lookup
          2. Klotz JL, McDowell KJ. Tall fescue ergot alkaloids are vasoactive in equine vasculature.. J Anim Sci 2017 Nov;95(11):5151-5160.
            doi: 10.2527/jas2017.1852pubmed: 29293720google scholar: lookup
          3. Rosenkrans CF Jr, Ezell NS. Relationships among ergot alkaloids, cytochrome P450 activity, and beef steer growth.. Front Chem 2015;3:16.
            doi: 10.3389/fchem.2015.00016pubmed: 25815288google scholar: lookup
          4. Guerre P. Ergot alkaloids produced by endophytic fungi of the genus Epichloë.. Toxins (Basel) 2015 Mar 6;7(3):773-90.
            doi: 10.3390/toxins7030773pubmed: 25756954google scholar: lookup